Researchers at the University of Pittsburgh School of Medicine have identified an agent that in lab tests protected the skin and lungs from fibrosis, a process that can ultimately end in organ failure and even death because ...
May 30, 2012
0
1
People with bipolar disorder, schizophrenia and major depression with psychosis may be up to 15 more likely than the general population to be HIV positive, but are only marginally more likely to be tested for the virus, according ...
Jan 18, 2017
0
18
A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer's ...
Apr 24, 2019
0
202
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
Most people in the United States have some degree of immune protection against COVID-19, either from vaccination, infection, or a combination of the two. But, just how much protection does any individual person have?
Aug 9, 2022
0
46
As the novel coronavirus spreads, it's picking up new mutations—for better and for worse.
Aug 13, 2020
0
89
Why do some people develop Alzheimer's disease while others don't? And, even more puzzlingly, why do many individuals whose brains are chock-full of toxic amyloid aggregates—a telltale sign of Alzheimer's brain pathology—never ...
May 29, 2023
0
141
The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn's disease has identified a genetic marker which could individualise drug treatment.
Oct 7, 2019
0
663
(HealthDay)—It's a drug that's been supported by some conservative media figures, but taking ivermectin to treat or prevent COVID-19 might land you in the hospital, a new study warns.
Oct 21, 2021
0
35
Scientists from Singapore's Nanyang Technological University (NTU Singapore) and McLean Hospital and Harvard Medical School in the United States have found that existing anti-malaria drugs could be a potential treatment for ...
Jul 16, 2015
0
155
